Molnupiravir, sold under the brand name Lagevrio, is an antiviral medication that inhibits the replication of certain RNA viruses. It is used to treat...
53 KB (4,209 words) - 15:49, 11 March 2024
PANORAMIC trial (section Molnupiravir)
preexisting health condition. The antivirals tested in the study will be molnupiravir and nirmatrelvir/ritonavir (Paxlovid). In December 2022, results from...
6 KB (525 words) - 08:27, 20 October 2023
the first company to obtain production and marketing authorization for molnupiravir, the first and only specific oral anti-covid drug in Bangladesh along...
6 KB (482 words) - 17:58, 5 April 2024
Feline infectious peritonitis (section Molnupiravir)
of Cyprus, on 8 August 2023 the government released 80,000 anti-COVID molnupiravir pills from its national COVID-19 stockpile, in a bid to solve the feline...
26 KB (2,913 words) - 20:50, 8 May 2024
adjusted its treatment guidelines. Among other changes, remdesivir and molnupiravir were now recommended only for the most severe cases, and deuremidevir...
372 KB (32,326 words) - 03:15, 13 May 2024
being actively studied in clinical trials. These include the antivirals molnupiravir (developed by Merck), and nirmatrelvir/ritonavir (developed by Pfizer)...
288 KB (32,866 words) - 02:35, 16 May 2024
include molnupiravir, high-dose nitazoxanide, the monoclonal antibody Vir 7832, intravenous favipiravir, and the combination of molnupiravir plus nirmatrelvir/ritonavir...
8 KB (878 words) - 18:33, 20 March 2024
COVID-19 drug development (section Molnupiravir)
molnupiravir's mutagenic effects could create new variants that evade immunity and prolong the COVID‑19 pandemic. In September 2023, molnupiravir's mutagenicity...
90 KB (13,107 words) - 20:17, 24 March 2024
being actively studied in clinical trials. These include the antivirals molnupiravir (developed by Merck), and nirmatrelvir/ritonavir (developed by Pfizer)...
68 KB (6,412 words) - 18:38, 19 February 2024
health and nutrition products including the oral anti covid medication Molnupiravir & Nirmatrelvir co-packaged with Ritonavir and injectable Remdesivir....
4 KB (256 words) - 16:33, 15 March 2024
COVID-19 antivirals including paxlovid (nirmatrelvir/ritonavir) and molnupiravir on acute COVID-19 outcomes and long COVID. Including work which evaluated...
13 KB (1,293 words) - 02:56, 13 May 2024
revealed that private firm MERCK was the sole importer of anti-COVID drugs Molnupiravir and Ronapreve on the island of Mauritius. Kailesh Jagutpal further revealed...
20 KB (2,145 words) - 21:47, 15 May 2024
in funding to help develop Molnupiravir. Merck & Co. partnered with Ridgeback to perform clinical trials with Molnupiravir in humans to treat COVID-19...
6 KB (547 words) - 14:35, 30 October 2023
Sotrovimab Tixagevimab/cilgavimab Tocilizumab Small molecule antivirals Broad-spectrum Ensitrelvir Molnupiravir Remdesivir Co-packaged Nirmatrelvir ritonavir...
181 KB (23,901 words) - 14:23, 6 January 2024
Minaprine Mirtazapine Misoprostol - Hospital authorization only. Moclobemide Molnupiravir Moperone Naloxone Naltrexone Nefazodone Nialamide Isobutyl nitrite Nomifensine...
26 KB (1,685 words) - 02:08, 21 February 2024
HIV Loviride HIV Maraviroc HIV entry inhibitor Methisazone Smallpox Molnupiravir COVID-19 viral RNA polymerase inhibitor Moroxydine Influenza Nelfinavir...
13 KB (513 words) - 14:31, 4 May 2024
treat millions of people in countries such as Yemen and African nations. Molnupiravir is an antiviral pill to treat COVID-19, developed in partnership with...
95 KB (9,333 words) - 15:23, 17 May 2024
(~380 patients × 2) clinical trial launched a year ago reports that molnupiravir substantially reduced the risk of hospitalization (7.3% to 14.1%) and...
297 KB (38,840 words) - 15:07, 9 May 2024
of other antiviral drugs targeting COVID-19, including remdesivir and molnupiravir. In a study of 428 patients, viral load was reduced, but symptoms were...
15 KB (996 words) - 07:31, 19 April 2024
(SARS-CoV-2) Coronaviridae droplet contact coronavirus disease 2019 (COVID-19) Molnupiravir, Nirmatrelvir/ritonavir hand washing covering mouth when coughing or...
36 KB (1,249 words) - 19:27, 19 May 2024
government unit in the country to procure anti-COVID-19 medicines such as Molnupiravir, Remdesivir, Tocilizumab, Baricitinib, and Bexovid for aged 12 and above...
180 KB (15,813 words) - 03:27, 13 April 2024
Merck Sharp & Dohme (MSD) to purchase the experimental antiviral pill molnupiravir. If approved by Medsafe, Pharmac will be supplied with 60,000 courses...
265 KB (17,624 words) - 01:33, 17 April 2024
Government was negotiating with Merck & Co to procure stocks of its antiviral molnupiravir pills for treating COVID-19. The Malaysian Deputy Education Minister...
25 KB (1,876 words) - 12:44, 15 November 2023
additional federal funding to Ridgeback Biotherapeutics to further develop molnupiravir into a treatment for COVID-19. He argued that although the drug had shown...
30 KB (2,767 words) - 10:05, 19 November 2023
for vulnerable patients to obtain a range of drugs including paxlovid, molnupiravir, and remdesivir. Timeline of the COVID-19 pandemic in July 2022 Responses...
3 KB (200 words) - 10:53, 19 May 2023
speed of classical supercomputers. Scientists report that repurposed Molnupiravir can completely suppress SARS-CoV-2 transmission within 24 hours in ferrets...
152 KB (27,233 words) - 06:48, 11 March 2024
government was negotiating with Merck & Co to procure stocks of its antiviral molnupiravir pills for treating COVID-19. Under the Movement Control Order put in...
221 KB (16,303 words) - 13:48, 8 May 2024
in the UK: The UK becomes the first country in the world to approve molnupiravir, an oral antiviral pill for COVID-19 that cuts the risk of hospitalisation...
347 KB (33,561 words) - 21:34, 18 May 2024
adjusted its treatment guidelines. Among other changes, remdesivir and molnupiravir were now recommended only for the most severe cases, and deuremidevir...
171 KB (16,045 words) - 18:24, 12 May 2024
marketing authorisation, to Promomed, for Esperavir, a drug based on molnupiravir and developed for the treatment of COVID-19. In April 2022, Ministry...
17 KB (1,269 words) - 09:55, 6 May 2024